Novartis (NVS)
(Delayed Data from NYSE)
$120.89 USD
+0.47 (0.39%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $120.83 -0.06 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO10/29/24 |
---|---|
Current Quarter | 1.91 |
EPS Last Quarter | 1.97 |
Last EPS Surprise | 5.35% |
ABR | 2.57 |
Earnings ESP
|
-1.94% |
---|---|
Current Year | 7.48 |
Next Year | 8.29 |
EPS (TTM) | 7.04 |
P/E (F1) | 16.16 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.43B | 12.64B | 49.70B | 52.50B |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 12.50B | 12.78B | 50.63B | 54.52B |
Low Estimate | 12.34B | 12.54B | 49.22B | 51.51B |
Year ago Sales | 11.78B | 11.42B | 49.78B | 49.70B |
Year over Year Growth Est. | 5.50% | 10.68% | -0.16% | 5.64% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.91 | 1.86 | 7.48 | 8.29 |
# of Estimates | 5 | 3 | 7 | 7 |
Most Recent Consensus | 1.88 | 1.85 | 7.50 | 8.19 |
High Estimate | 1.96 | 1.91 | 7.59 | 8.82 |
Low Estimate | 1.87 | 1.81 | 7.35 | 7.75 |
Year ago EPS | 1.74 | 1.53 | 6.90 | 7.48 |
Year over Year Growth Est. | 9.77% | 21.57% | 8.41% | 10.79% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 6 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.91 | 1.86 | 7.48 | 8.29 |
7 Days Ago | 1.91 | 1.86 | 7.48 | 8.29 |
30 Days Ago | 1.91 | 1.84 | 7.42 | 8.26 |
60 Days Ago | 1.86 | 1.82 | 7.29 | 8.20 |
90 Days Ago | 1.86 | 1.82 | 7.28 | 8.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.88 | 1.85 | 7.43 | 7.97 |
Zacks Consensus Estimate | 1.91 | 1.86 | 7.48 | 8.29 |
Earnings ESP | -1.94% | -0.36% | -0.77% | -3.86% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.97 | 1.80 | 1.53 | 1.74 | NA |
Estimate | 1.87 | 1.73 | 1.64 | 1.70 | NA |
Difference | 0.10 | 0.07 | -0.11 | 0.04 | 0.03 |
Surprise | 5.35% | 4.05% | -6.71% | 2.35% | 1.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more